Drug Delivery Technology Market Size, Share, Analysis and Forecast 2032
Drug Delivery Technology Market By End-user (home care settings, hospitals, diagnostic centers, ambulatory surgical centers, and other facilities of use), By Route of administration (ocular drug delivery, pulmonary drug delivery, injectable drug delivery, oral drug delivery, implantable drug delivery, topical drug delivery, parenteral route, transmucosal drug delivery, and nasal drug delivery) And By Region: - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts, 2024-2032
| Market Size in 2023 | Market Forecast in 2032 | Growth Rate (in %) | Base Year |
|---|---|---|---|
| USD 39.64 Billion | USD 73.19 Billion | CAGR at 7.05% | 2023 |
Description
What is the Market size of the Drug Delivery Technology Industry?
According to the report published by Zion Market Research, the global Drug Delivery Technology Market size was valued at USD 39.64 Billion? in 2023 and is predicted to reach USD 73.19 Billion? by the end of 2032. The market is expected to grow with a CAGR of 7.05% during the forecast period. The report analyzes the global Drug Delivery Technology Market’s growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Drug Delivery Technology Market industry.
Request Free SampleRequest Free Sample
Global Drug Delivery Technology Market: Overview
Drug delivery system is the method of delivering therapeutic substance via a general route of administration to attain a therapeutic effect in animals or humans. Drugs liberate the functional ingredients in the area of the target at a correct dose and at the appropriate time. Drug delivery technologies enhance the drug release profile, distribution, absorption, and elimination for the sake of developing product safety and efficiency coupled with patient ease and conformity.
Global Drug Delivery Technology Market: Growth Factors
The key factors fueling the growth of the global drug delivery technology market include the increasing incidence of chronic diseases, advancement in technologies, the rising attention on geriatric & pediatric patients, the growth in biologics market, the transformation in lifestyle owing to rising urbanization, launch of novel product, and the growing need for minimum invasive surgeries. In addition, the home care & self-administration and increasing need for generic drugs and biosimilars are few other factors driving the market growth. However, patent expiry, the risk of needle-stick injuries, regulatory obstacles, and side-effects associated with drugs are some factors that may restrict the growth of the market.
Request Free SampleRequest Free Sample
Global Drug Delivery Technology Market: Segmentation
The global drug delivery technology market can be segmented on the basis of end-user, route of administration, and region.
The end-user segment of the market is classified into home care settings, hospitals, diagnostic centers, ambulatory surgical centers, and other facilities of use.
The route of administration segment of the market is diversified into ocular drug delivery, pulmonary drug delivery, injectable drug delivery, oral drug delivery, implantable drug delivery, topical drug delivery, parenteral route, transmucosal drug delivery, and nasal drug delivery.The pulmonary drug delivery segment of the market is divided into dry powder inhaler, metered dose inhaler, and nebulizers. The implantable drug delivery segment of the market is classified into passive implantable drug delivery and active implantable drug delivery. The parenteral route segment of the drug delivery technology market is sub-segmented into intra-arteria, intramuscular, subcutaneous route, and intravenous.
Geographically, the market is categorized into Europe, North America, Asia-Pacific, Latin America, and the Middle East & Africa.
Recent Developments:
- In July 2025, AbbVie acquired Capstan Therapeutics for up to $2.1 billion, adding its in vivo CAR-T platform, which uses targeted lipid nanoparticles to deliver mRNA for the treatment of autoimmune diseases. The deal brings in the lead candidate CPTX2309 for B-cell disorders and supports AbbVie’s push toward scalable, chemo-free immune-reset therapies without complex ex vivo manufacturing.
- In January 2025, Phillips Medisize, a Molex company, acquired Vectura Group Ltd., expanding its inhalation drug delivery portfolio with added expertise in dry-powder inhalers, metered-dose inhalers, nasal inhalers, and nebulizers, and strengthening its pharmaceutical device design and manufacturing capabilities.
- In January 2025, Nipro and Nemera confirmed compatibility between Nemera’s UniSpray device and Nipro’s unit-dose microvials, advancing single-dose nasal drug delivery by pairing precision glass vials with an intuitive spray device.
Drug Delivery Technology Market : Report Scope
| Report Attributes | Report Details |
|---|---|
| Report Name | Drug Delivery Technology Market Research Report |
| Market Size in 2023 | USD 39.64 Billion |
| Market Forecast in 2032 | USD 73.19 Billion |
| Growth Rate | CAGR of 7.05% |
| Number of Pages | 196 |
| Key Companies Covered | Merck & Co., Inc., Pfizer, Inc., Johnson & Johnson, Inc., Bayer AG, F. Hoffman-La Roche, and Novartis AG. The other key players in the market include Sanofi, 3M Company, Antares Pharma, Inc., GlaxoSmithKline plc, and Becton, Dickinson, and Company |
| Segments Covered | By End-user, By Route of administration and By Region |
| Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
| Base Year | 2023 |
| Historical Year | 2018 to 2022 |
| Forecast Year | 2024 - 2032 |
| Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Global Drug Delivery Technology Market: Regional Analysis
North America is expected to dominate the global drug delivery technology market in the near future. Asia Pacific region is also anticipated to grow at a faster rate in the coming period owing to the funds by key companies in the field of R&D activities and low price of clinical trials and labor.
Global Drug Delivery Technology Market: Competitive Players
The prominent players in the global drug delivery technology market are:
- Merck & Co., Inc.
- Pfizer, Inc.
- Johnson & Johnson, Inc.
- Bayer AG
- F. Hoffman-La Roche
- Novartis AG
The other key players in the market include
- Sanofi
- 3M Company
- Antares Pharma, Inc.
- GlaxoSmithKline plc
- Becton
- Dickinson
- Company.
The Global Drug Delivery Technology Market is segmented as follows:
By End-user
- home care settings
- hospitals
- diagnostic centers
- ambulatory surgical centers
- and other facilities of use
By Route of administration
- ocular drug delivery
- pulmonary drug delivery
- injectable drug delivery
- oral drug delivery
- implantable drug delivery
- topical drug delivery
- parenteral route
- transmucosal drug delivery
- nasal drug delivery
By Region
What Report Provides
- Full in-depth analysis of the parent market
- Important changes in market dynamics
- Segmentation details of the market
- Former, on-going, and projected market analysis in terms of volume and value
- Assessment of niche industry developments
- Market share analysis
- Key strategies of major players
- Emerging segments and regional markets
- Testimonials to companies in order to fortify their foothold in the market.
Table Of Content
FrequentlyAsked Questions
Drug delivery technology refers to methods and systems designed to deliver medications effectively to targeted areas in the body.
The global drug delivery technology market is expected to be driven by the The market is driven by demand for targeted and controlled drug delivery, rising chronic disease burden, and continuous innovation in nanotechnology and biologics-based delivery systems.
According to study, the global drug delivery technology market size was worth around USD 39.64 Billion in 2023 and is predicted to grow to around USD 73.19 Billion By 2032.
The global drug delivery technology market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 7.05% during the forecast period from 2024-2032.
The global drug delivery technology industry is projected to be challenged by High R&D costs, complex regulatory pathways, and safety concerns around novel delivery systems hinder adoption. Scaling technologies from trials to commercialization is also challenging.
The Opportunities lie in long-acting injectables, targeted delivery, biologics support, and growth in smart devices and microneedles improving adherence and outcomes will offer significant growth opportunities in the drug delivery technology market.
Targeted and controlled-release systems, biologics delivery innovation, and smart drug delivery devices are the emerging trends and innovations impacting the drug delivery technology market.
The global drug delivery technology market is expected to be led by North America during the forecast period.
Some of the prominent players operating in the global drug delivery technology market are; Merck & Co., Inc., Pfizer, Inc., Johnson & Johnson, Inc., Bayer AG, F. Hoffman-La Roche, and Novartis AG. The other key players in the market include Sanofi, 3M Company, Antares Pharma, Inc., GlaxoSmithKline plc, and Becton, Dickinson, and Company and others.
The report explores crucial aspects of the drug delivery technology market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients
